FACTORS AFFECTING INTERMEDIATE-DOSE METHOTREXATE (MTX) CLEARANCE (CL) IN THE TREATMENT OF ACUTE LYMPHOCYTIC-LEUKEMIA (ALL)

被引：0
|
作者：
CROM, WR [1 ]
GLYNN, AM [1 ]
EVANS, WE [1 ]
机构：
[1] ST JUDE CHILDRENS RES HOSP,DIV PHARMACEUT,PHARMACOKINET & PHARMACODYNAM SECT,MEMPHIS,TN 38101
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1985年 / 37卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：188 / 188
页数：1
相关论文
共 50 条
  • [31] High-dose compared with intermediate-dose methotrexate in children with a first relapse of acute lymphatic leukemia
    Cohen, Ian J.
    BLOOD, 2008, 112 (03) : 910 - 910
  • [32] High-dose compared with intermediate-dose methotrexate in children with a first relapse of acute lymphoblastic leukemia
    von Stackelberg, Arend
    Hartmann, Reinhard
    Buehrer, Christoph
    Fengler, Ruediger
    Janka-Schaub, Gritta
    Reiter, Alfred
    Mann, Georg
    Schmiegelow, Kjeld
    Ratei, Richard
    Klingebiel, Thomas
    Ritter, Joerg
    Henze, Guenter
    BLOOD, 2008, 111 (05) : 2573 - 2580
  • [33] POSSIBLE ADVERSE INFLUENCE OF ADMINISTERING INTRATHECAL METHOTREXATE (IT-MTX) NON-CONCURRENTLY WITH CRANIAL RADIOTHERAPY (CRT) IN THE TREATMENT OF CHILDHOOD ACUTE LYMPHOCYTIC-LEUKEMIA (ALL)
    JANKASCHAUB, GE
    GOEBEL, U
    GUTJAHR, P
    JUERGENS, H
    SPAAR, HJ
    WINKLER, K
    MEDICAL AND PEDIATRIC ONCOLOGY, 1988, 16 (06): : 394 - 394
  • [34] HIGH-DOSE METHOTREXATE FOR THE REMISSION INDUCTION OF REFRACTORY ADULT ACUTE LYMPHOCYTIC-LEUKEMIA
    PETERSON, BA
    BLOOMFIELD, CD
    MEDICAL AND PEDIATRIC ONCOLOGY, 1978, 5 : 79 - 84
  • [35] EVALUATION OF MONITORING CRITERIA FOR HIGH-DOSE METHOTREXATE IN CHILDREN WITH ACUTE LYMPHOCYTIC-LEUKEMIA
    CHRISTENSEN, ML
    CHOI, KE
    RIVERA, G
    EVANS, WE
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1985, 19 (06): : 467 - 467
  • [36] ORAL MUCOSITIS AND SALIVARY METHOTREXATE CONCENTRATION IN INTERMEDIATE-DOSE METHOTREXATE THERAPY FOR CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
    ISHII, E
    YAMADA, SI
    HIGUCHI, S
    HONJO, T
    IGARASHI, H
    KANEMITSU, S
    KAI, T
    UEDA, K
    MEDICAL AND PEDIATRIC ONCOLOGY, 1989, 17 (05): : 429 - 432
  • [37] Nephrotoxicity due to intermediate-dose methotrexate without rescue in an obese adolescent with acute lymphoblastic leukemia
    Sauer, M
    Rydholm, N
    Piatkowski, J
    Lewis, V
    Steiner, M
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2002, 19 (02) : 135 - 140
  • [38] BIOCHEMICAL INTERACTIONS BETWEEN METHOTREXATE (MTX) AND 1-BETA-D-ARABINOFURANOSYLCYTOSINE (ARA-C) IN PATIENTS WITH ACUTE LYMPHOCYTIC-LEUKEMIA (ALL)
    NEWMAN, EM
    TESTI, AM
    PINKEL, D
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 133 - 133
  • [39] TREATMENT OF ACUTE NONLYMPHOBLASTIC LEUKEMIA WITH INTERMEDIATE-DOSE CYTOSINE-ARABINOSIDE AND MITOXANTRONE
    ERTOP, S
    BOLAMAN, Z
    BILGIR, O
    YOGURUCU, Y
    YILMAZ, E
    MUFTUOGLU, E
    JOURNAL OF CHEMOTHERAPY, 1993, 5 : 668 - 668
  • [40] TREATMENT OF RELAPSED ACUTE MYELOID-LEUKEMIA WITH IDARUBICIN AND INTERMEDIATE-DOSE CYTARABINE
    HAROUSSEAU, JL
    REIFFERS, J
    HURTELOUP, P
    MILPIED, N
    GUY, H
    RIGALHUGUET, F
    FACON, T
    DUFOUR, P
    IFRAH, N
    JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (01) : 45 - 49
12345